SEC Form 4 · accession 0001104659-18-071881
BioXcel Therapeutics, Inc. · BTAI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Mueller
Director
Period of report
Dec 6, 2018
Accepted (ET)
Dec 7, 2018 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720893
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 6, 2018 | P | 1,295 | $5.00 | A | 150,820 | D | |
| Common Stock | Dec 6, 2018 | P | 100 | $5.01 | A | 150,920 | D | |
| Common Stock | Dec 7, 2018 | P | 495 | $5.00 | A | 151,415 | D | |
| Common Stock | Dec 7, 2018 | P | 6,905 | $5.01 | A | 158,320 | D |
Table II — derivative securities
No Table II lines on this filing.